Cargando…

Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects

Beta-thalassemia major (TM) remains to be one of the major health problems particularly in developing countries. Tunisia is a part of the Mediterranean countries mostly affected by this disease which is highly concentrated in small towns in families with low-income earners. The main objectives of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bejaoui, Mohamed, Guirat, Naouel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552730/
https://www.ncbi.nlm.nih.gov/pubmed/23350015
http://dx.doi.org/10.4084/MJHID.2013.002
_version_ 1782256710032818176
author Bejaoui, Mohamed
Guirat, Naouel
author_facet Bejaoui, Mohamed
Guirat, Naouel
author_sort Bejaoui, Mohamed
collection PubMed
description Beta-thalassemia major (TM) remains to be one of the major health problems particularly in developing countries. Tunisia is a part of the Mediterranean countries mostly affected by this disease which is highly concentrated in small towns in families with low-income earners. The main objectives of this study are to provide a description of the demographic, clinical features and transfusion-related complications in patients with TM living in Tunisia. A standardized questionnaire was sent to clinicians throughout 33 different medical institutions caring for thalassemic patients. 391 transfusion dependant thalassemic patients with a median age of 10.7 years (range 3 months- 31 years) were included in the study. The majority originated from the north west of the country. A moderate iron overload between 1501 and 2500 ng/ml was found in 61patients, while 81 patients (26.9%) had a ferritin level more than 2500 ng/ml and greater than 5000ng/ml in 21 patients (6.9%). 51 patients died from complications related to their disease. Heart failure was the main cause of death. The incidence of cardiac, endocrine, and infectious complications will be reviewed. Preventive measures such as health education, carrier screening and premarital screening remain the best ways for lowering the incidence of these diseases, which might be reflected in financial saving, social s and health benefits.
format Online
Article
Text
id pubmed-3552730
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Università Cattolica del Sacro Cuore
record_format MEDLINE/PubMed
spelling pubmed-35527302013-01-24 Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects Bejaoui, Mohamed Guirat, Naouel Mediterr J Hematol Infect Dis Original Articles Beta-thalassemia major (TM) remains to be one of the major health problems particularly in developing countries. Tunisia is a part of the Mediterranean countries mostly affected by this disease which is highly concentrated in small towns in families with low-income earners. The main objectives of this study are to provide a description of the demographic, clinical features and transfusion-related complications in patients with TM living in Tunisia. A standardized questionnaire was sent to clinicians throughout 33 different medical institutions caring for thalassemic patients. 391 transfusion dependant thalassemic patients with a median age of 10.7 years (range 3 months- 31 years) were included in the study. The majority originated from the north west of the country. A moderate iron overload between 1501 and 2500 ng/ml was found in 61patients, while 81 patients (26.9%) had a ferritin level more than 2500 ng/ml and greater than 5000ng/ml in 21 patients (6.9%). 51 patients died from complications related to their disease. Heart failure was the main cause of death. The incidence of cardiac, endocrine, and infectious complications will be reviewed. Preventive measures such as health education, carrier screening and premarital screening remain the best ways for lowering the incidence of these diseases, which might be reflected in financial saving, social s and health benefits. Università Cattolica del Sacro Cuore 2013-01-02 /pmc/articles/PMC3552730/ /pubmed/23350015 http://dx.doi.org/10.4084/MJHID.2013.002 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Bejaoui, Mohamed
Guirat, Naouel
Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects
title Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects
title_full Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects
title_fullStr Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects
title_full_unstemmed Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects
title_short Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects
title_sort beta thalassemia major in a developing country: epidemiological, clinical and evolutionary aspects
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552730/
https://www.ncbi.nlm.nih.gov/pubmed/23350015
http://dx.doi.org/10.4084/MJHID.2013.002
work_keys_str_mv AT bejaouimohamed betathalassemiamajorinadevelopingcountryepidemiologicalclinicalandevolutionaryaspects
AT guiratnaouel betathalassemiamajorinadevelopingcountryepidemiologicalclinicalandevolutionaryaspects